Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

CHA University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1999-01-01

Employees: -

Market Cap: -

Website: http://www.cha.ac.kr

Clinical Trials

Treatment Efficacy of Mindfulness-based Cognitive Therapy for Distress in Advanced Cancer Patients

Not Applicable

Conditions: Distress, Emotional
Cancer Pain
Psychiatric or Mood Diseases or Conditions
Cancer
Therapy-Associated Cancer
Psychological Distress

Interventions: Behavioral: Mindfulness-Based Cognitive-behavioral Therapy for Distress

First Posted Date: 2023-03-14

Last Posted Date: 2023-04-05

Lead Sponsor: CHA University

Target Recruit Count: 40

Registration Number: NCT05768256

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Kyeonggi-do, Korea, Republic of

Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced Cholangiocarcinoma

Recruiting

Conditions: Locally Advanced Cholangiocarcinoma

First Posted Date: 2023-01-10

Last Posted Date: 2024-02-07

Lead Sponsor: CHA University

Target Recruit Count: 100

Registration Number: NCT05677217

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

ROMIAE (Rule-Out Acute Myocardial Infarction Using Artificial Intelligence Electrocardiogram Analysis) Trial

Conditions: Myocardial Infarction or Chest Pain

First Posted Date: 2022-06-28

Last Posted Date: 2022-06-28

Lead Sponsor: CHA University

Target Recruit Count: 8814

Registration Number: NCT05435391

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam, Korea, Republic of

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Not Applicable

Recruiting

Conditions: Cervical Cancer

Interventions: Procedure: Surgical debulking of bulky or multiple lymph nodes
Radiation: CCRT

First Posted Date: 2022-06-16

Last Posted Date: 2025-04-09

Lead Sponsor: CHA University

Target Recruit Count: 240

Registration Number: NCT05421650

Locations: 🇮🇳
Aster CMI Hospital, Bengaluru, India
🇮🇹
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
🇰🇷
Soon Chun Hyang University Hospital Cheonan, Cheonan, Chungcheongnam-do, Korea, Republic of

and more 23 locations

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy

Recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Drug: atezolizumab plus bevacizumab

First Posted Date: 2022-01-19

Last Posted Date: 2023-02-21

Lead Sponsor: CHA University

Target Recruit Count: 100

Registration Number: NCT05197504

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Recruiting

Conditions: Advanced Hepatocellular Carcinoma

Interventions: Drug: atezolizumab plus bevacizumab

First Posted Date: 2021-12-29

Last Posted Date: 2024-02-07

Lead Sponsor: CHA University

Target Recruit Count: 100

Registration Number: NCT05173298

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis

Phase 1

Recruiting

Conditions: Sepsis

Interventions: Drug: Dexamethasone

First Posted Date: 2021-11-29

Last Posted Date: 2025-05-31

Lead Sponsor: CHA University

Target Recruit Count: 102

Registration Number: NCT05136560

Locations: 🇰🇷
Bundang CHA hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷
Samsung Hospital, Seoul, Korea, Republic of

Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC

Phase 2

Active, not recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Drug: regorafenib

First Posted Date: 2021-11-26

Last Posted Date: 2023-04-26

Lead Sponsor: CHA University

Target Recruit Count: 40

Registration Number: NCT05134532

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Comparison of Focused ESWT by Frequency for Patients With Myofascial Pain Syndrome

Not Applicable

Conditions: Myofascial Pain Syndrome

Interventions: Device: Extracorporeal shockwave therapy

First Posted Date: 2021-08-10

Last Posted Date: 2021-08-10

Lead Sponsor: CHA University

Target Recruit Count: 20

Registration Number: NCT04998630

Locations: 🇰🇷
Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Online Mental Health Program for Female College Students

Not Applicable

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Behavioral: Online Mental Health Program

First Posted Date: 2021-07-29

Last Posted Date: 2021-07-29

Lead Sponsor: CHA University

Target Recruit Count: 34

Registration Number: NCT04982523

Locations: 🇰🇷
CHA University, Pocheon-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy